Healthcare AI Adoption and Regulation Expand as Clinical Evidence Lags

A Q3 tracker reports 40 enacted AI bills across 24 states, California requirements spanning chatbot safety, health-data privacy, and clinical decision support, and federal exploration of payment and regulatory pathways. FDA counts more than 1,600 authorized AI-enabled devices by September 2026 and AI components in over 500 drug submissions, but adoption and authorization do not establish improved outcomes. A small GMP batch-record review study reported promising issue detection and speed, but its four-record, single-campaign evaluation requires broader validation.